(Q34401825)

1 August 2017

title

Enobosarm (GTx-024, S-22): a potential treatment for cachexia (English)

1 reference

1 August 2017

Reshmi Srinath

1

1 reference

1 August 2017

Adrian Dobs

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

1 August 2017

1 reference

1 August 2017

volume

10

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

187-194

1 reference

Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Cachexia: a new definition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Definition and classification of cancer cachexia: an international consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Cachexia versus sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Cachexia: prevalence and impact in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Pharmacological options for advanced cancer patients with loss of appetite and weight

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.273

https://api.fatcat.wiki/v0/release/32ifkd67c5etbez2hcfdni4u6a

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_32ifkd67c5etbez2hcfdni4u6a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/32ifkd67c5etbez2hcfdni4u6a

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/32ifkd67c5etbez2hcfdni4u6a

1 reference